Prot# CL011_168:A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan (CCX168) in Patients with C3 Glomerulopathy

Project: Research project

Project Details

StatusFinished
Effective start/end date3/14/18 → 3/14/23

Funding

  • Medpace Clinical Research LLC (Prot# CL011_168 // Prot# CL011_168)
  • ChemoCentryx, Inc. (Prot# CL011_168 // Prot# CL011_168)